slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 68,401-68,430
Pages 3,679
Rows per page 30
Component
68,401-68,430 of 110,355
12
The slide uses a waterfall bridge to explain the movement in net debt, highlighting CFO, Capex, deal payments, and dividends.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
13
Slide 13 of a presentation deck.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
15
CER = constant exchange rates; ERoW = Established Rest of World.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
17
Includes a Kaplan-Meier survival curve and a study design flow chart.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
18
The slide uses a split-panel layout to compare two different drug programs, each supported by clinical trial data (Kaplan-Meier curves and waterfall plots).AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
19
Includes a visual representation of antibody-drug conjugate mechanism on the left.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
23
Slide uses a grid layout to present product-specific commercial updates.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
26
Includes a trial design diagram for tozorakimab and indication expansion status for Saphnelo.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
30
The slide uses a two-column layout to contrast two distinct R&D programs.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
35
The slide uses color coding to distinguish between Oncology (maroon), BioPharmaceuticals (teal), and Rare Disease (not explicitly shown in the legend but implied by the color scheme).AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
36
The slide uses a dot chart to show historical ratings and a list-based scorecard for qualitative ESG performance.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
39
The slide contains two stacked bar charts with corresponding data tables below them.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
40
Data presented as stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
41
Data presented as stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
43
Data presented as stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
02
Includes a date note at the bottom: 'Note: Unless otherwise stated, this presentation is as of January 6th, 2023'ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
03
The slide uses a numbered list to present five key pillars of the company's value proposition.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
04
The slide uses a hierarchical structure to connect a high-level objective to three specific operational pillars.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
05
The slide uses a Gantt-style visualization to represent drug development stages.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
Uses a timeline-style visual to represent the 'need' metrics.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
The slide uses a bar chart to show dose-dependent efficacy across three cognitive tests (HVLT, Symbol Coding, Category Fluency).ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The slide uses a vertical process flow to demonstrate the de-risking of the drug candidate.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
11
The slide highlights the efficacy of RL-007 in cognitive endpoints during a Phase 2 study.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
12
The slide uses a standard clinical trial flow diagram to illustrate the study protocol.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
13
The slide uses a feature-comparison matrix to highlight the competitive advantage of RL-007.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · Competitive AnalysisLoop · Golden Circle1 hit
15
The slide uses a dual-column layout: left side establishes the scale of the problem (market sizing/context), right side details the clinical pain points.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
16
The slide uses a line chart to demonstrate the efficacy of different dosages of COMP360 over 12 weeks.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
17
The slide uses a timeline-based process diagram to illustrate clinical trial protocols.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
18
The slide uses a split layout: a left-hand sidebar for product summary and a right-hand side for clinical data visualization.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit
21
The slide uses a combination of a disease overview, a map-based infographic, and a vertical timeline-style list to highlight the market opportunity.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Golden Circle1 hit